No published data exist examining its pharmacokinetic or pharmacodynamic interactions with any other peptide, meaning the potential for additive side effects, unexpected hormonal disruption, or dangerous interactions is entirely unknown
10.1053/j.gastro.2016.03.038 55
For those with preserved ejection fraction (HFpEF), GLP-1 medications reduced the composite of cardiovascular death or worsening heart failure events by 32% 15
Vansh Kumar and Jason M
Effendi, A., Lestari, V., & Irsyad, M
For Sjgrens syndrome and ankylosing spondylitis, we dont yet have specific large trials but the same underlying biology applies: calm the metabolic inflammation, and the autoimmune attack often calms with it